Back to Search
Start Over
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.
- Source :
-
Blood . 11/8/2018, Vol. 132 Issue 19, p2097-2100. 4p. - Publication Year :
- 2018
-
Abstract
- The article discusses the treatment effectiveness of combination drugs including nelfinavir, bortezomib, and dexamethasone in the treatment of proteasome inhibitor-refractory multiple myeloma. The treatment response in patients with relapsed and refractory multiple myeloma is accessed. Topics including the response rate of the drugs, the medication safety and efficacy of the treatment, and the survival analysis.
Details
- Language :
- English
- ISSN :
- 00064971
- Volume :
- 132
- Issue :
- 19
- Database :
- Academic Search Index
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 132912068
- Full Text :
- https://doi.org/10.1182/blood-2018-05-851170